Female Patients With Sleep-Disordered Breathing Display More Frequently Heart Failure With Preserved Ejection Fraction

Simon Lebek, Philipp Hegner, Maria Tafelmeier, Leopold Rupprecht, Christof Schmid, Lars Siegfried Maier, Michael Arzt, Stefan Wagner, Simon Lebek, Philipp Hegner, Maria Tafelmeier, Leopold Rupprecht, Christof Schmid, Lars Siegfried Maier, Michael Arzt, Stefan Wagner

Abstract

Objective: Sleep-disordered breathing (SDB) is a widespread disease that is often associated with heart failure (HF) with preserved ejection fraction (HFpEF). HFpEF is more frequent in women than in men, but detailed pathomechanisms remain unclear. We investigated HFpEF in women and men in a high-risk cohort with SDB monitoring. Methods and Results: Three hundred twenty-seven patients (84.4% men) undergoing elective coronary artery bypass grafting were prospectively subjected to SDB monitoring, and an apnea-hypopnea index (AHI) ≥15/h defined SDB. HF was classified according to current guidelines. HFpEF was significantly more frequent in SDB patients compared to those without SDB (28 vs. 17%, P = 0.016). This distribution was driven by an increased frequency of HFpEF in female SDB patients (48% vs. only 25% in male, P = 0.022). In accordance, female patients with SDB exhibited significantly more impaired diastolic left ventricular filling compared to men (echocardiographic E/e'). In contrast to men, in women, minimum oxygen saturation (O2min, measured by polygraphy, R 2 = 0.470, P < 0.001) and time of oxygen saturation <90% (R 2 = 0.165, P = 0.044) were significantly correlated with E/e'. Moreover, the correlation between O2min and E/e' was significantly different in women compared to men (P < 0.001). Intriguingly, this association remained independent of clinical covariates in women [age, body mass index, systolic contractile dysfunction, diabetes mellitus, and glomerular filtration rate (GFR), R 2 = 0.534, P = 0.042, multivariate regression analysis]. Since angiotensin II signaling has been mechanistically linked to HF, we measured protein expression of its cleavage enzyme ACE2 in human right atrial appendage biopsies (Western blot). Intriguingly, we found a significantly decreased ACE2 expression preferentially in women with SDB (2.66 ± 0.42 vs. 4.01 ± 2.47 in men with SDB, P = 0.005). In accordance, left ventricular mass index was significantly increased in women with SDB compared to women without SDB. Conclusion: In patients with SDB, HFpEF and diastolic dysfunction were more frequent in women compared to men. In contrast to men, the severity of SDB was associated with the degree of diastolic dysfunction in women. These insights might help to find sex-specific therapies for patients with sleep-disordered breathing and heart failure. Clinical Trial Registration: Unique identifier: NCT02877745, URL: http://www.clinicaltrials.gov.

Keywords: ACE2; HFpEF; gender; intermittent hypoxia; sex; sleep-disordered breathing.

Conflict of interest statement

MA received consulting fees from ResMed, Philips Respironics, Boehringer-Ingelheim, NRI, Novartis, Bayer, and Bresotec, and grant supports from ResMed as well as ResMed Foundation, all outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Lebek, Hegner, Tafelmeier, Rupprecht, Schmid, Maier, Arzt and Wagner.

Figures

Figure 1
Figure 1
Study flowchart. Study flowchart showing the enrolment of 415 patients undergoing elective coronary artery bypass grafting. After exclusion of 88 patients, 166 patients without SDB and 161 patients with SDB (± right atrial appendage biopsies) were prospectively analyzed.
Figure 2
Figure 2
Increased frequency of HFpEF in women with SDB. (A) Proportion of patients having heart failure with preserved ejection fraction (HFpEF). Interestingly, HFpEF was significantly more common in women with SDB (N = 11/23) compared to men with SDB (N = 34/138). (B) Accordingly, the severity of diastolic dysfunction, estimated by E/e′, was significantly increased in women with SDB (N = 9) compared to women without SDB (N = 16) and men with SDB (N = 50). (C) This resulted in significant correlations between E/e′ with both O2min and time of oxygen saturation <90% (% of total recording time) in women but not in men, indicating that hypoxia may be involved in HFpEF-development in women. (D) Original Western blots for the analysis of ACE2 expression in right atrial appendage biopsies. (E) Intriguingly, densiometric analyses revealed that ACE2 expression was significantly decreased in women with SDB (N = 4), leading to a significant correlation with O2min in women (N = 10) but not in men (N = 82). Statistical comparisons are based on (A) chi-square test (B,E), one-way analysis of variance (ANOVA), and (C,E) linear regression analysis.
Figure 3
Figure 3
Diastolic dysfunction in women with SDB. (A) In accordance with an increased frequency of heart failure in women and men with SDB (Table 1), we observed a significantly increased level of NT-pro BNP in women (N = 19 vs. N = 27) and men (N = 126 vs. N = 119) with SDB. (B) Early diastolic mitral annulus velocity (e′) was significantly decreased in women with SDB (N = 8), indicating diastolic dysfunction. (C) Moreover, left atrial area index was significantly increased in women with SDB (N = 14) compared to women without SDB (N = 15), leading to a significant correlation with O2min in women but not in men. (D) Consistently, we observed a trend toward an increased left atrial volume index in women with SDB (N = 4 vs. N = 6). Statistical comparisons are based on (A,B) Kruskal–Wallis test (C,D) one-way analysis of variance (ANOVA), and (C) linear regression analysis.
Figure 4
Figure 4
Cardiac remodeling in patients with SDB. (A) Left ventricular mass index was significantly increased in women with SDB (N = 8) compared to women without SDB (N = 17). (B) Accordingly, we observed a significantly increased QRS width in women with SDB (N = 18) and a significant correlation with O2min in women (N = 41) (C), proposing that hypoxemia may be especially relevant for myocardial hypertrophy in women. Statistical comparisons are based on (A,B) Kruskal–Wallis test, and (C) linear regression analysis.

References

    1. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. . Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. (2019) 7:687–98. 10.1016/S2213-2600(19)30198-5
    1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. (2013) 177:1006–14. 10.1093/aje/kws342
    1. Pengo MF, Soranna D, Giontella A, Perger E, Mattaliano P, Schwarz EI, et al. . Obstructive sleep apnoea treatment and blood pressure: which phenotypes predict a response? A systematic review and meta-analysis. Eur Respir J. (2020) 55:1901945. 10.1183/13993003.01945-2019
    1. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, et al. . Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. (2007) 49:565–71. 10.1016/j.jacc.2006.08.060
    1. Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, et al. . Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC. Heart Fail. (2016) 4:116–25. 10.1016/j.jchf.2015.09.014
    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. (2016) 37:2129–200. 10.1093/eurheartj/ehw128
    1. Buchner S, Greimel T, Hetzenecker A, Luchner A, Hamer OW, Debl K, et al. . Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J. (2012) 40:1173–9. 10.1183/09031936.00172211
    1. Lebek S, Pichler K, Reuthner K, Trum M, Tafelmeier M, Mustroph J, et al. . Enhanced CaMKII-dependent late ina induces atrial proarrhythmic activity in patients with sleep-disordered breathing. Circ Res. (2020) 126:603–15. 10.1161/CIRCRESAHA.119.315755
    1. Sharma S, Fox H, Aguilar F, Mukhtar U, Willes L, Bozorgnia B, et al. . Auto positive airway pressure therapy reduces pulmonary pressures in adults admitted for acute heart failure with pulmonary hypertension and obstructive sleep apnea. The ASAP-HF Pilot Trial. Sleep. (2019) 42:100. 10.1093/sleep/zsz100
    1. Gevaert AB, Boen JRA, Segers VF, van Craenenbroeck EM. Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology. Front Physiol. (2019) 10:638. 10.3389/fphys.2019.00638
    1. Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, et al. . Sex differences in heart failure. Eur Heart J. (2019) 40:3859–68. 10.1093/eurheartj/ehz835
    1. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. . Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. (2020) 126:1456–74. 10.1161/CIRCRESAHA.120.317015
    1. Tafelmeier M, Knapp M, Lebek S, Floerchinger B, Camboni D, Wittmann S, et al. . Rationale and design of the CONSIDER AF study. Somnologie. (2019) 23:17–28. 10.1007/s11818-019-0196-6
    1. Berry RB, Gamaldo CE, Harding SM, Brooks R, Lloyd RM, Vaughn BV, et al. . AASM scoring manual version 2.2 updates: new chapters for scoring infant sleep staging and home sleep apnea testing. J Clin Sleep Med. (2015) 11:1253–4. 10.5664/jcsm.5176
    1. Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, et al. . AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med. (2017) 13:665–6. 10.5664/jcsm.6576
    1. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, et al. . Lifetime risk for developing congestive heart failure: The Framingham Heart Study. Circulation. (2002) 106:3068–72. 10.1161/01.cir.0000039105.49749.6f
    1. Solomon SD McMurray JJV Anand IS Ge J Lam CSP Maggioni AP . Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. (2019) 381:1609–20. 10.1056/NEJMoa1908655
    1. McMurray JJV Jackson AM Lam CSP Redfield MM Anand IS Ge J . Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF. Circulation. (2020) 141:338–51. 10.1161/CIRCULATIONAHA.119.044491
    1. Tromp J, MacDonald MR, Tay WT, Teng THK, Hung CL, Narasimhan C, et al. . Heart failure with preserved ejection fraction in the young. Circulation. (2018) 138:2763–73. 10.1161/CIRCULATIONAHA.118.034720
    1. Tromp J Shen L Jhund PS Anand IS Carson PE Desai AS . Age-related characteristics and outcomes of patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. (2019) 74:601–12. 10.1016/j.jacc.2019.05.052
    1. Ceia F, Fonseca C, Mota T, Morais H, Matias F, Sousa A, et al. . Prevalence of chronic heart failure in Southwestern Europe: The EPICA study. Eur J Heart Fail. (2002) 4:531–9. 10.1016/s1388-9842(02)00034-x
    1. Gessner V, Bitter T, Horstkotte D, Oldenburg O, Fox H. Impact of sleep-disordered breathing in patients with acute myocardial infarction: a retrospective analysis. J Sleep Res. (2017) 26:657–64. 10.1111/jsr.12540
    1. Abdullah A, Eigbire G, Salama A, Wahab A, Nadkarni N, Alweis R. Relation of obstructive sleep apnea to risk of hospitalization in patients with heart failure and preserved ejection fraction from the national inpatient sample. Am J Cardiol. (2018) 122:612–5. 10.1016/j.amjcard.2018.04.052
    1. Hwang SJ, Melenovsky V, Borlaug BA. Implications of coronary artery disease in heart failure with preserved ejection fraction. J Am Coll Cardiol. (2014) 63:2817–27. 10.1016/j.jacc.2014.03.034
    1. Michowitz Y, Arbel Y, Wexler D, Sheps D, Rogowski O, Shapira I, et al. . Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol. (2008) 125:347–51. 10.1016/j.ijcard.2007.02.037
    1. Masiha S, Sundström J, Lind L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens. (2013) 27:13–7. 10.1038/jhh.2011.113
    1. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Wachtell K, Papademetriou V, et al. . Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The losartan intervention for endpoint reduction. J Hypertens. (2001) 19:1883–91. 10.1097/00004872-200110000-00025
    1. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol. (2007) 292:C82–97. 10.1152/ajpcell.00287.2006
    1. Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, et al. . Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. (2020) 41:1810–7. 10.1093/eurheartj/ehaa373
    1. Li R, Uttarwar L, Gao B, Charbonneau M, Shi Y, Chan JSD, et al. . High glucose up-regulates ADAM17 through HIF-1α in mesangial cells. J Biol Chem. (2015) 290:21603–14. 10.1074/jbc.M115.651604
    1. Zhang R, Su H, Ma X, Xu X, Liang L, Ma G, et al. . MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2. Am J Physiol Lung Cell Mol Physiol. (2019) 316:L547–57. 10.1152/ajplung.00387.2018
    1. Lebek S, Tafelmeier M, Messmann R, Provaznik Z, Schmid C, Maier LS, et al. . Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease. Eur J Heart Fail. (2020) 22:2248–57. 10.1002/ejhf.2020
    1. Zampino M, Yuzhakova M, Hansen J, McKinney RD, Goldspink PH, Geenen DL, et al. . Sex-related dimorphic response of HIF-1 alpha expression in myocardial ischemia. Am J Physiol Heart Circul Physiol. (2006) 291:H957–64. 10.1152/ajpheart.00580.2005
    1. Yang J, AlTahan A, Jones DT, Buffa FM, Bridges E, Interiano RB, et al. . Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer. Proc Natl Acad Sci USA. (2015) 112:15172–7. 10.1073/pnas.1422015112
    1. Kang NN, Fu L, Xu J, Han Y, Cao JX, Sun JF, et al. . Testosterone improves cardiac function and alters angiotensin II receptors in isoproterenol-induced heart failure. Arch Cardiovasc Dis. (2012) 105:68–76. 10.1016/j.acvd.2011.12.002
    1. Chung CC, Hsu RC, Kao YH, Liou JP, Lu YY, Chen YJ. Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling. Int J Cardiol. (2014) 176:386–93. 10.1016/j.ijcard.2014.07.077
    1. Dalpiaz PLM, Lamas AZ, Caliman IF, Ribeiro RF, Abreu GR, Moyses MR, et al. . Sex hormones promote opposite effects on ace and ace2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats. PLoS ONE. (2015) 10:e0127515. 10.1371/journal.pone.0127515
    1. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, et al. . Aromatase–a brief overview. Annu Rev Physiol. (2002) 64:93–127. 10.1146/annurev.physiol.64.081601.142703
    1. Tafelmeier M, Luft L, Zistler E, Floerchinger B, Camboni D, Creutzenberg M, et al. . Central sleep apnea predicts pulmonary complications after cardiac surgery. Chest. (2021) 159:798–809. 10.1016/j.chest.2020.07.080
    1. German Clinical Trials Register. DRKS - Deutsches Register Klinischer Studien. (2021). Available online at: (accessed April 8, 2021).

Source: PubMed

3
Prenumerera